Validation of Prognostic Scales for Functional Outcome in Ischemic Stroke Patients Treated with Intravenous Thrombolysis in a Rural Setting
Cerebrovascular Diseases Extra · 2024
DOI: 10.1159/000541801 ↗Kurz gefasst
Validierungsstudie in der Zeitschrift Cerebrovascular Diseases Extra, 2024. Verfasst von Andrea Loggini und 5 weiteren Autor:innen. Beteiligte Einrichtung: Brain and Spine Institute, Southern Illinois Healthcare, Carbondale, Illinois, USA. Hauptthemen laut MEDLINE: Thrombolytic Therapy, Predictive Value of Tests, Fibrinolytic Agents, Ischemic Stroke. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 17 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Themen: Schlaganfall
Abstract (Originalsprache)
Introduction
Early prediction of functional outcome after rtPA helps clinicians in prognostic conversations with stroke patients and their families. Three prognostic tools have been developed in this regard: DRAGON, MRI-DRAGON, and S-TPI scales. These tools, all performing with comparable accuracy, have been internally and externally validated in tertiary care centers. However, their performance in rural areas remains uncertain. This study addresses this gap in the literature by evaluating the effectiveness of those prognostic tools in stroke patients treated in a rural area of the Midwest.
Methods
We conducted a retrospective study of stroke patients treated with thrombolytics at Southern Illinois Healthcare Stroke Network from July 2017 to June 2024. Data on demographics, clinical presentations, laboratory values, neuroimaging, and stroke metrics were collected. Modified Rankin Scale (mRS) at 1 month, classified into good (mRS ≤2) and poor (mRS ≥5) outcomes were noted. DRAGON and MRI-DRAGON scores were calculated. S-TPI model was built. Area under the receiver operating characteristic curve (AUC) with its 95% confidence interval was calculated for each prognostic model.
Results
A total of 279 patients were included in this study. Of those, 43% (n = 119) were male. Median age (interquartile range [IQR]) was 69 (57–80) years. NIHSS at presentation (IQR) was 7 (4–13). 12% of the cohort (n = 34) had posterior circulation stroke. At 1 month, 66% of patients (n = 185) had mRS ≤2, whereas 14% of patients (n = 39) had mRS ≥5. MRI-DRAGON showed the highest accuracy in predicting both good (AUC = 0.86, 95% CI: 0.81–0.90) and poor outcomes (AUC = 0.84, 95% CI: 0.76–0.91). DRAGON also demonstrated high accuracy for good (AUC = 0.85, 95% CI: 0.80–0.89) and poor (AUC = 0.82, 95% CI: 0.75–0.90) outcomes. Conversely, in our population, the S-TPI model had the lowest accuracy for good (AUC = 0.56, 95% CI: 0.49–0.63) and poor (AUC = 0.68, 95% CI: 0.61–0.76) outcomes.
Conclusion
Among the available grading scores, MRI-DRAGON score can be considered the more accurate short-term prognostic tool for stroke patients treated with rtPA in the rural setting.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Brain and Spine Institute, Southern Illinois Healthcare, Carbondale, Illinois, USA.
- Southern Illinois University School of Medicine, Carbondale, Illinois, USA.
- Department of Neurology, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, USA.
Zitieren
APA
Loggini, A., Saleh Velez, F. G., Hornik, J., Henson, J., Wesler, J., & Hornik, A. (2024). Validation of Prognostic Scales for Functional Outcome in Ischemic Stroke Patients Treated with Intravenous Thrombolysis in a Rural Setting. Cerebrovascular Diseases Extra. https://doi.org/10.1159/000541801
Vancouver
Loggini A, Saleh Velez FG, Hornik J, Henson J, Wesler J, Hornik A. Validation of Prognostic Scales for Functional Outcome in Ischemic Stroke Patients Treated with Intravenous Thrombolysis in a Rural Setting. Cerebrovascular Diseases Extra. 2024. doi:10.1159/000541801
BibTeX
@article{Loggini2024,
author = {Loggini, Andrea and Saleh Velez, Faddi G and Hornik, Jonatan and Henson, Jessie and Wesler, Julie and Hornik, Alejandro},
title = {Validation of Prognostic Scales for Functional Outcome in Ischemic Stroke Patients Treated with Intravenous Thrombolysis in a Rural Setting},
journal = {Cerebrovascular Diseases Extra},
year = {2024},
doi = {10.1159/000541801}
}
EUVIMED